Skip to content

BioRestorative CEO Discusses Regenerative Medicine Advancements on The Big Biz Show

Catch up on BioRestorative's latest advancements in regenerative medicine. CEO Lance Alstodt shares insights on the company's commercial prospects and innovative treatments.

This is a poster in this image there are different types of bones, and at the bottom and top of the...
This is a poster in this image there are different types of bones, and at the bottom and top of the image there is some text.

BioRestorative CEO Discusses Regenerative Medicine Advancements on The Big Biz Show

BioRestorative Therapies, Inc. (BRTX) CEO Lance Alstodt recently discussed the company's future commercial real estate opportunities and recent milestones on The Big Biz Show, which aired on cable TV, streaming services, radio, and various podcast platforms. The interview highlighted significant prospects and advancements in the field of regenerative medicine.

BioRestorative operates a commercial BioCosmeceutical platform with a product aimed at reducing fine lines and wrinkles. The company's lead cell therapy candidate, BRTX-100, is currently in a Phase 2 clinical trial for chronic lower back pain and has also received FDA IND clearance for treating chronic cervical discogenic pain. In the interview, Alstodt emphasized the company's pursuit of regenerative medicine solutions and therapies aimed at improving patients' quality of life through innovative treatments.

BioRestorative's metabolic syndrome program, ThermoStem, is designed to target obesity and metabolic disorders using brown adipose-derived stem cells. The company is exploring the expansion of its commercial offering to include more cell-based biologic aesthetic products. Alstodt discussed the company's recent clinical and regulatory milestones, demonstrating BioRestorative's progress in the field.

BioRestorative Therapies, Inc. continues to make strides in the regenerative medicine sector. With its commercial BioCosmeceutical platform, lead cell therapy candidate BRTX-100, and metabolic program ThermoStem, the company is pursuing innovative solutions to improve patients' lives. The interview with CEO Lance Alstodt on The Big Biz Show underscored the company's significant commercial opportunities and recent achievements.

Read also:

Latest